Management of patients with advanced prostate cancer—metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022
Silke Gillessen(University of Bern), Ken Herrmann(Klinikum rechts der Isar), Kim N.(BC Cancer Agency), Eric J. Small(CancerCare Manitoba), Karim Fizazi(Institut Gustave Roussy), Pierre Blanchard(Inserm), Anders Bjartell(Malmö University), Emmanuel S. Antonarakis(Johns Hopkins University), Felix Y. Feng(University of Michigan), Bertrand Tombal(Cliniques Universitaires Saint-Luc), Robert G. Bristow(Cancer Research UK Manchester Institute), Ana M. Aparicio(The University of Texas MD Anderson Cancer Center), Nicholas D. James(University of Warwick), Daniel Castellano(Universidad Complutense de Madrid), Orazio Caffo(Ospedale Santa Chiara), Alberto Briganti(Vita-Salute San Raffaele University), Ignacio Durán(Instituto de Biomedicina de Sevilla), Andrew J. Armstrong(Duke Medical Center), Heather H. Cheng(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Himisha Beltran(Cornell University), Gedske Daugaard(Copenhagen University Hospital), Tomasz M. Beer(Oregon Health & Science University), Jason A. Efstathiou(Massachusetts General Hospital), Caroline S. Clarke(The Royal Free Hospital), Susan Halabi(Duke University), Nicolas Mottet(University of Copenhagen), Valérie Fonteyne(Ghent University Hospital), Stefano Fanti(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), Muhammad Bulbul(American University of Beirut Medical Center), Martin Gleave(University of British Columbia), Ian D. Davis(Eastern Health), Noel W. Clarke(Manchester Academic Health Science Centre), Mark Frydenberg(Monash University), Gwénaëlle Gravis(Institut Paoli-Calmettes), Johann S. de Bono(Royal Marsden NHS Foundation Trust), Elena Castro(Hospital Universitario 12 De Octubre), Nicola Fossati(Ospedale regionale di Lugano), Eleni Efstathiou(The University of Texas MD Anderson Cancer Center), Neal D. Shore(Carolina Urologic Research Center), Christopher P. Evans(University of California, Davis), Matthew R. Smith(Massachusetts General Hospital), Alberto Bossi(Institut Gustave Roussy), Maria De Santis(Medical University of Vienna), Daniel Heinrich(San Antonio College), Ross Eeles(Royal Marsden NHS Foundation Trust), Onyeanunam Ngozi Ekeke(University of Port Harcourt Teaching Hospital), Dan George(Duke University), Gerhardt Attard(Royal Marsden NHS Foundation Trust), Simon Chowdhury(Guy's Hospital), Christopher J. Sweeney(Dana-Farber Cancer Institute)
Cited by 156
Related Papers
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k
Integrative Clinical Genomics of Advanced Prostate Cancer
|Cell|2015|3.6k
Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer
|New England Journal of Medicine|2013|3.3k
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
|New England Journal of Medicine|2014|3k